These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34532454)

  • 1. DAB2IP decreases cell growth and migration and increases sensitivity to chemotherapeutic drugs in colorectal cancer.
    Wu G; Xu X; Wan D; Zhou D; Feng Y; Chen J; Peng Z; Fang D; Shi X; Yao H; Chen G; Sun L; Yao Y; Zhou G; Yang Y; He S
    Ann Transl Med; 2021 Aug; 9(16):1317. PubMed ID: 34532454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation.
    Zhou Y; Yang Z; Zhang H; Li H; Zhang M; Wang H; Zhang M; Qiu P; Zhang R; Liu J
    Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166353. PubMed ID: 35063646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-889 promotes cell proliferation in colorectal cancer by targeting DAB2IP.
    Xiao Y; Li ZH; Bi YH
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3326-3334. PubMed ID: 31081086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-182 contributes to cell proliferation, invasion and tumor growth in colorectal cancer by targeting DAB2IP.
    Li X; Zhang X; Zhang Q; Lin R
    Int J Biochem Cell Biol; 2019 Jun; 111():27-36. PubMed ID: 30974224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer.
    Wang J; Zhu X; Hu J; He G; Li X; Wu P; Ren X; Wang F; Liao W; Liang L; Ding Y
    Oncotarget; 2015 Sep; 6(29):27427-39. PubMed ID: 26336990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of FAT4 enhances the chemosensitivity of colorectal cancer cells treated by 5-FU.
    Li Q; Zhou X; Fang Z; Pan Z; Zhou H
    Transl Cancer Res; 2020 Jan; 9(1):309-322. PubMed ID: 35117185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells.
    Duan Y; Yin X; Lai X; Liu C; Nie W; Li D; Xie Z; Li Z; Meng F
    Technol Cancer Res Treat; 2020; 19():1533033819895494. PubMed ID: 32336215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway.
    Sun L; Yao Y; Lu T; Shang Z; Zhan S; Shi W; Pan G; Zhu X; He S
    Gastroenterol Res Pract; 2018; 2018():2968252. PubMed ID: 29743885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer.
    Min J; Liu L; Li X; Jiang J; Wang J; Zhang B; Cao D; Yu D; Tao D; Hu J; Gong J; Xie D
    Sci Rep; 2015 Nov; 5():16578. PubMed ID: 26564738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DAB2IP-knocking down resulted in radio-resistance of breast cancer cells is associated with increased hypoxia and vasculogenic mimicry formation.
    Zhang X; Wang Q; Zhang R; Kong Z
    Int J Radiat Biol; 2023; 99(10):1595-1606. PubMed ID: 36947637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer.
    Shen YJ; Kong ZL; Wan FN; Wang HK; Bian XJ; Gan HL; Wang CF; Ye DW
    Cancer Sci; 2014 Jun; 105(6):704-12. PubMed ID: 24684735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircFAM114A2 Suppresses Cell Proliferation, Migration, and Invasion of Colorectal Cancer Through Sponging miR-647 to Upregulate DAB2IP Expression.
    Huang G; Sun D; Hu X; Wang Q
    Biochem Genet; 2024 Jul; ():. PubMed ID: 38970722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer.
    Wang G; Wang X; Han M; Wang X
    Onco Targets Ther; 2021; 14():979-988. PubMed ID: 33603402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2.
    Zhu XH; Wang JM; Yang SS; Wang FF; Hu JL; Xin SN; Men H; Lu GF; Lan XL; Zhang D; Wang XY; Liao WT; Ding YQ; Liang L
    Int J Cancer; 2017 Jul; 141(1):172-183. PubMed ID: 28335083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesin Component Member STAG2 Enhances Cisplatin Tolerance in Colorectal Cancer Cells through the Epithelial-Mesenchymal Transition Pathway.
    Zhou P; Ye M; Chen C; Zhang R
    Recent Pat Anticancer Drug Discov; 2024 Jul; ():. PubMed ID: 38963118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAB2IP with tumor-inhibiting activities exhibits frameshift mutations in gastrointestinal cancers.
    Son HJ; Jo YS; Kim MS; Yoo NJ; Lee SH
    Pathol Res Pract; 2018 Dec; 214(12):2075-2080. PubMed ID: 30477644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DAB2IP down-regulates HSP90AA1 to inhibit the malignant biological behaviors of colorectal cancer.
    Zhang M; Peng Y; Yang Z; Zhang H; Xu C; Liu L; Zhao Q; Wu J; Wang H; Liu J
    BMC Cancer; 2022 May; 22(1):561. PubMed ID: 35590292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
    Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y
    Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 Suppression Improved the Chemosensitivity of HT-29 Colorectal Cancer Cells to 5-Fluorouracil and Inhibited Cell Migration.
    Najafi S; Rahimi Z; Mansoori B; Mohammadi A; Mohammadnejad F; Amini M; Mokhtazadeh A; Asadzadeh Z; Chi-Shing Cho W; Baradaran B
    Adv Pharm Bull; 2023 Jul; 13(3):551-562. PubMed ID: 37646068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.